SLC39A14 and Hepatic fibrosis: The observed dynamic changes in transcription factor binding and acetylation motifs on the ZIP14 provide critical insights into the regulatory mechanisms underlying the therapeutic effects of ZnCl2 treatment on liver fibrosis.